External Contamination of Cytotoxic Drug Vials

Abstract

Journal of Pharmacy Practice and ResearchVolume 35, Issue 4 p. 264-265 EditorialFree Access External Contamination of Cytotoxic Drug Vials Peter J Gilbar BPharm, MPallC, FISOPP, FSHP, DipHospClinPharmPract Co-Chair, Peter J Gilbar BPharm, MPallC, FISOPP, FSHP, DipHospClinPharmPract Co-Chair [email protected] Committee of Specialty Practice in Oncology The Society of Hospital Pharmacists of Australia, Senior Pharmacist—Oncology/Palliative Care Toowoomba Health Services, Toowoomba, Qld, 4350 AustraliaSearch for more papers by this author Peter J Gilbar BPharm, MPallC, FISOPP, FSHP, DipHospClinPharmPract Co-Chair, Peter J Gilbar BPharm, MPallC, FISOPP, FSHP, DipHospClinPharmPract Co-Chair [email protected] Committee of Specialty Practice in Oncology The Society of Hospital Pharmacists of Australia, Senior Pharmacist—Oncology/Palliative Care Toowoomba Health Services, Toowoomba, Qld, 4350 AustraliaSearch for more papers by this author First published: 13 April 2015 https://doi.org/10.1002/j.2055-2335.2005.tb00359.xCitations: 10AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL No abstract is available for this article. References 1Baker ES, Connor TH. Monitoring occupational exposure to cancer chemotherapy drugs. Am J Health Syst Pharm 1996; 15: 2713– 23. 2 The Society of Hospital Pharmacists of Australia. Committee of Specialty Practice in Oncology. SHPA standards of practice for the safe handling of cytotoxic drugs in pharmacy departments. J Pharm Pract Res 2005; 35: 44– 52. 3Falck K, Grohn P, Sorsa M, Vainio H, Helnonen E, Holsti LR. Mutagenicity in urine of nurses handling cytotoxic drugs. Lancet 1979; 1: 1250– 1. 4Connor TH, Anderson RW, Sessink PJM, Broadfield L, Power LA. Surface contamination with antineoplastic agents in six cancer treatment centres in Canada and the United States. Am J Health Syst Pharm 1999; 56: 1427– 32. 5Ros JJW, Simons KA, Verzijl JM, et al. Practical applications of a validated method of analysis for the detection of traces of cyclophosphamide on injection bottles at an oncological outpatients centre. Ziekenhuisfarmacie 1997; 13: 168– 71. 6Delporte JP, Chenoix P, Hubert P. Chemical contamination of the primary packaging of 5-fluorouracil RTU solutions commercially available on the Belgian market. Environ Health Perspect 1999; 5: 119– 21. 7Nygren O, Gustavsson B, Strom L, Friberg A. Cisplatin contamination observed on the outside of drug vials. Ann Occup Hyg 2002; 46: 555– 7. 8Mason HJ, Morton J, Garfitt SJ, Iqbal S, Jones K. Cytotoxic drug contamination on the outside of vials delivered to a hospital pharmacy. Ann Occup Hyg 2003; 47: 681– 5. 9Favier B, Gilles L, Ardiet C, Latour JF. External contamination of vials containing cytotoxic agents supplied by pharmaceutical manufacturers. J Oncol Pharm Pract 2003; 9: 15– 20. 10Connor TH, Sessink PJM, Harrison B, et al. Surface contamination of chemotherapy drug vials and evaluation of new vial-cleaning techniques: results of three studies. Am J Health Syst Pharm 2005; 62: 475– 84. 11Schultz H, Bigelow S, Dobish R, Chambers CR. Antineoplastic agent workplace contamination study: the Alberta Cancer Board Pharmacy perspective. J Oncol Pharm Pract 2005; 11: 101– 9. 12Power LA. Demand clean vials [editorial]. Am J Health Syst Pharm 2005; 62: 471. Citing Literature Volume35, Issue4December 2005Pages 264-265 ReferencesRelatedInformation